The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 29, 2020

Filed:

Jun. 11, 2019
Applicant:

Church & Dwight Co., Inc., Princeton, NJ (US);

Inventors:

Ovidiu Romanoschi, Highland Park, NJ (US);

Caryn Oryniak, Hillsborough, NJ (US);

Luis C. Muniz, Brooklyn, NY (US);

Hiep Huatan, Kent, GB;

Nazim Kanji, Leicester, GB;

Huw Jones, Nottingham, GB;

Lindsey Bagley, Berkshire, GB;

Graham Godfrey, Worcestershire, GB;

Assignee:

Church & Dwight Co., Inc., Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 33/42 (2006.01); A23G 3/36 (2006.01); A23G 3/54 (2006.01); A61K 9/20 (2006.01); A61K 31/167 (2006.01); A61K 31/19 (2006.01); A61K 31/197 (2006.01); A61K 31/375 (2006.01); A61K 31/4545 (2006.01); A61K 31/519 (2006.01); A61K 31/616 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0056 (2013.01); A23G 3/36 (2013.01); A23G 3/54 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2072 (2013.01); A61K 31/167 (2013.01); A61K 31/19 (2013.01); A61K 31/197 (2013.01); A61K 31/375 (2013.01); A61K 31/4545 (2013.01); A61K 31/519 (2013.01); A61K 31/616 (2013.01); A61K 33/42 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01);
Abstract

The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of: a first component including a gummy composition; a second component that is a particulate material or is a pre-formed solid unit or plurality of pre-formed solid units; and an active ingredient. The second component can be, for example, in the form of a pharmaceutically acceptable oral dosage unit, such as a tablet, a caplet, a soft shell capsule, a hard shell capsule, a microcapsule, or a pastille.


Find Patent Forward Citations

Loading…